NASDAQ : VTGN
Vistagen Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Vistagen Therapeutics, Inc. (VTGN) reported revenue of 2.50M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Revenue | 2.50M | 1.27M | 486.00K | 1.06M | -227.00K | 1.11M |
| Gross Profit | 2.50M | 1.27M | 486.00K | 1.06M | -227.00K | 1.11M |
| Selling, General & Admin | 17.97M | 18.42M | 17.08M | 14.06M | 14.66M | 13.96M |
| Research & Development | 54.20M | 54.97M | 39.38M | 20.02M | 44.38M | 34.92M |
| Operating Expenses | 72.17M | 73.39M | 56.46M | 34.09M | 59.04M | 48.89M |
| Operating Income | -69.67M | -72.13M | -55.97M | -33.02M | -59.27M | -47.78M |
| Interest & Investment Income | 2.05M | 2.44M | 4.56M | 3.35M | 26.00K | 19.90K |
| Other Non Operating Income (Expenses) | 8.00K | 7.00K | 5.00K | 312.00K | ||
| EBT Excluding Unusual Items | -67.61M | -69.68M | -51.41M | -29.36M | -59.24M | -47.76M |
| Pretax Income | -67.61M | -69.68M | -51.41M | -29.36M | -59.24M | -47.76M |
| Income Tax Expense | 7.00K | 7.00K | 7.00K | 4.00K | 6.00K | 3.40K |
| Net Income | -67.62M | -69.69M | -51.42M | -29.36M | -59.25M | -47.76M |
| Preferred Dividends & Other Adjustments | 945.10K | |||||
| Net Income to Common | -67.62M | -69.69M | -51.42M | -29.36M | -59.25M | -48.71M |
| Shares Outstanding (Basic) | 40.84M | 38.07M | 30.88M | 19.35M | 6.96M | 6.60M |
| Shares Outstanding (Diluted) | 40.84M | 38.07M | 30.88M | 19.35M | 6.96M | 6.60M |
| EPS (Basic) | -1.66 | -1.83 | -1.67 | -1.52 | -8.51 | -7.38 |
| EPS (Diluted) | -1.66 | -1.83 | -1.67 | -1.52 | -8.51 | -7.38 |
| Free Cash Flow | -62.38M | -66.59M | -42.29M | -25.87M | -49.93M | -45.46M |
| Free Cash Flow Per Share | -1.53 | -1.75 | -1.37 | -1.34 | -7.17 | -6.89 |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | |
| Operating Margin | -2,785.69% | -5,683.69% | -11,517.08% | -3,103.48% | -4,308.68% | |
| Profit Margin | -2,703.72% | -5,491.33% | -10,579.83% | -2,759.59% | -4,392.42% | |
| Free Cash Flow Margin | -2,494.32% | -5,247.20% | -8,701.24% | -2,431.77% | -4,099.28% | |
| EBITDA | -69.46M | -71.93M | -55.82M | -32.89M | -59.14M | -47.63M |
| D&A For EBITDA | 211.00K | 199.00K | 150.00K | 127.00K | 130.00K | 153.50K |
| EBIT | -69.67M | -72.13M | -55.97M | -33.02M | -59.27M | -47.78M |
| Revenue as Reported | 2.50M | 1.27M | 486.00K | 1.06M | -227.00K | 1.11M |
Balance sheet
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 16.99M | 30.79M | 67.13M | 119.17M | 16.64M | 68.14M |
| Short-Term Investments | 14.74M | 14.61M | 13.35M | |||
| Cash & Short-Term Investments | 31.73M | 45.40M | 80.48M | 119.17M | 16.64M | 68.14M |
| Other Receivables | 337.90K | |||||
| Receivables | 337.90K | |||||
| Prepaid Expenses | 2.58M | 1.54M | 1.59M | 1.51M | 802.00K | 196.50K |
| Other Current Assets | 67.00K | 2.33M | ||||
| Total Current Assets | 34.31M | 46.94M | 82.08M | 120.67M | 17.51M | 71.00M |
| Property, Plant & Equipment | 1.03M | 1.23M | 1.81M | 2.25M | 2.77M | 3.08M |
| Long-Term Deferred Charges | 37.00K | 56.00K | 130.00K | 714.00K | 468.20K | |
| Other Long-Term Assets | 355.00K | 337.00K | 324.00K | 726.00K | 101.00K | 100.90K |
| Total Assets | 35.74M | 48.56M | 84.34M | 123.65M | 21.09M | 74.64M |
| Accounts Payable | 1.00M | 1.53M | 653.00K | 1.55M | 2.47M | 2.76M |
| Accrued Expenses | 9.24M | 8.76M | 8.81M | 2.23M | 796.00K | 1.33M |
| Short-Term Debt | 96.00K | 105.00K | ||||
| Current Portion of Leases | 720.00K | 699.00K | 561.00K | 550.00K | 486.00K | 433.30K |
| Current Unearned Revenue | 234.00K | 1.71M | 2.59M | 791.00K | 714.00K | 1.24M |
| Total Current Liabilities | 11.19M | 12.79M | 12.61M | 5.12M | 4.57M | 5.77M |
| Long-Term Leases | 63.00K | 249.00K | 948.00K | 1.57M | 2.12M | 2.61M |
| Long-Term Unearned Revenue | 391.00K | 2.67M | 2.31M | 1.56M | ||
| Total Liabilities | 11.26M | 13.04M | 13.95M | 9.37M | 9.01M | 9.93M |
| Common Stock | 44.00K | 40.00K | 29.00K | 27.00K | 7.00K | 6.90K |
| Additional Paid-In Capital | 518.76M | 516.77M | 481.96M | 474.44M | 342.89M | 336.28M |
| Retained Earnings | -490.35M | -477.32M | -407.63M | -356.21M | -326.85M | -267.60M |
| Treasury Stock | -3.97M | -3.97M | -3.97M | -3.97M | -3.97M | -3.97M |
| Comprehensive Income & Other | -7.00K | -2.00K | 5.00K | |||
| Total Common Equity | 24.48M | 35.52M | 70.39M | 114.29M | 12.08M | 64.72M |
| Shareholders' Equity | 24.48M | 35.52M | 70.39M | 114.29M | 12.08M | 64.72M |
| Total Liabilities & Equity | 35.74M | 48.56M | 84.34M | 123.65M | 21.09M | 74.64M |
| Total Debt | 783.00K | 1.04M | 1.51M | 2.12M | 2.71M | 3.04M |
| Net Cash (Debt) | 30.95M | 44.36M | 78.97M | 117.05M | 13.93M | 65.10M |
| Net Cash Per Share | 0.76 | 1.17 | 2.56 | 6.05 | 2.00 | 9.86 |
| Filing Date Shares Outstanding | 44.38M | 41.03M | 29.16M | 27.03M | 7.87M | 6.89M |
| Total Common Shares Outstanding | 44.38M | 39.62M | 29.00M | 27.03M | 7.31M | 6.88M |
| Working Capital | 23.12M | 34.15M | 69.46M | 115.55M | 12.93M | 65.23M |
| Book Value Per Share | 0.55 | 0.90 | 2.43 | 4.23 | 1.65 | 9.40 |
| Tangible Book Value | 24.48M | 35.52M | 70.39M | 114.29M | 12.08M | 64.72M |
| Tangible Book Value Per Share | 0.55 | 0.90 | 2.43 | 4.23 | 1.65 | 9.40 |
| Machinery | 1.12M | 1.60M | 1.48M | 1.49M | 1.45M | |
| Leasehold Improvements | 194.00K | 221.00K | 214.00K | 214.00K | 214.40K |
Cash flow statement
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -67.62M | -69.69M | -51.42M | -29.36M | -59.25M | -47.76M |
| Depreciation & Amortization | 761.00K | 733.00K | 635.00K | 568.00K | 532.00K | 711.10K |
| Other Amortization | 232.00K | |||||
| Loss (Gain) From Sale of Assets | 6.00K | |||||
| Loss (Gain) From Sale of Investments | -547.00K | -543.00K | -389.00K | |||
| Stock-Based Compensation | 4.07M | 4.00M | 4.32M | 2.18M | 3.34M | 3.48M |
| Other Operating Activities | -3.00K | 3.64M | ||||
| Change in Accounts Payable | 3.20M | 828.00K | 5.68M | 522.00K | -934.00K | 1.69M |
| Change in Unearned Revenue | -2.43M | -1.20M | -412.00K | 516.00K | 206.00K | -1.00M |
| Change in Other Net Operating Assets | 268.00K | -571.00K | -509.00K | -245.00K | 2.75M | -2.60M |
| Operating Cash Flow | -62.30M | -66.44M | -42.10M | -25.81M | -49.72M | -45.26M |
| Capital Expenditures | -86.00K | -151.00K | -191.00K | -61.00K | -212.00K | -200.40K |
| Cash Acquisitions | -528.00K | |||||
| Investment in Securities | -3.00K | -726.00K | -12.96M | |||
| Investing Cash Flow | -89.00K | -877.00K | -13.15M | -61.00K | -740.00K | -200.40K |
| Short-Term Debt Issued | 1.02M | |||||
| Total Debt Issued | 1.02M | |||||
| Short-Term Debt Repaid | -925.00K | -985.00K | -1.03M | |||
| Long-Term Debt Repaid | -3.00K | |||||
| Total Debt Repaid | -931.00K | -925.00K | -985.00K | -1.03M | -3.00K | |
| Net Debt Issued (Repaid) | -931.00K | 95.00K | -985.00K | -1.03M | -3.00K | |
| Issuance of Common Stock | 31.32M | 30.88M | 3.21M | 129.39M | 167.00K | 10.49M |
| Other Financing Activities | -174.00K | |||||
| Financing Cash Flow | 30.39M | 30.97M | 3.21M | 128.40M | -1.04M | 10.48M |
| Net Cash Flow | -31.99M | -36.34M | -52.03M | 102.53M | -51.50M | -34.97M |
| Free Cash Flow | -62.38M | -66.59M | -42.29M | -25.87M | -49.93M | -45.46M |
| Free Cash Flow Margin | -2,494.32% | -5,247.20% | -8,701.24% | -2,431.77% | -4,099.28% | |
| Free Cash Flow Per Share | -1.53 | -1.75 | -1.37 | -1.34 | -7.17 | -6.89 |
| Levered Free Cash Flow | -36.95M | -40.50M | -22.83M | -18.00M | -32.74M | -25.98M |
| Unlevered Free Cash Flow | -36.95M | -40.50M | -22.83M | -18.00M | -32.74M | -26.21M |
| Cash Interest Paid | 27.00K | 33.00K | ||||
| Change in Working Capital | 1.04M | -938.00K | 4.76M | 793.00K | 2.03M | -1.92M |
Ratios
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 7.43M | 22.64M | 72.16M | 142.69M | 27.35M | 256.09M |
| Enterprise Value | -23.51M | -37.70M | -14.69M | 18.39M | 5.46M | 175.54M |
| Last Close Price | 0.17 | 0.57 | 2.50 | 5.28 | 3.74 | 37.20 |
| PS Ratio | 2.97 | 17.84 | 148.47 | 134.11 | -120.48 | 230.94 |
| PB Ratio | 0.30 | 0.64 | 1.02 | 1.25 | 2.26 | 3.96 |
| P/TBV Ratio | 0.30 | 0.64 | 1.02 | 1.25 | 2.26 | 3.96 |
| EV/Sales Ratio | 17.28 | 158.30 | ||||
| Debt / Equity Ratio | 0.03 | 0.03 | 0.02 | 0.02 | 0.22 | 0.05 |
| Net Debt / Equity Ratio | -1.26 | -1.25 | -1.12 | -1.02 | -1.15 | -1.01 |
| Net Debt / EBITDA Ratio | 0.45 | 0.62 | 1.42 | 3.56 | 0.24 | 1.37 |
| Net Debt / FCF Ratio | 0.50 | 0.67 | 1.87 | 4.52 | 0.28 | 1.43 |
| Asset Turnover | 0.05 | 0.02 | 0.01 | 0.01 | 0.01 | |
| Quick Ratio | 2.83 | 3.55 | 6.38 | 23.26 | 3.64 | 11.88 |
| Current Ratio | 3.07 | 3.67 | 6.51 | 23.55 | 3.83 | 12.31 |
| Return on Equity (ROE) | -166.46% | -131.59% | -55.68% | -46.47% | -154.30% | -58.62% |
| Return on Assets (ROA) | -83.21% | -67.84% | -33.64% | -28.52% | -77.39% | -32.65% |
| Return on Capital Employed (ROCE) | -283.90% | -201.60% | -78.00% | -27.90% | -358.90% | -69.40% |
| Earnings Yield | -988.59% | -307.75% | -71.26% | -20.58% | -216.63% | -18.65% |
| FCF Yield | -839.26% | -294.07% | -58.61% | -18.13% | -182.55% | -17.75% |
| Buyback Yield / Dilution | -30.85% | -23.31% | -59.53% | -178.13% | -5.45% | -129.85% |